SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Director/PDMR Shareholding

30 Apr 2026 13:05

RNS Number : 6388C
CLS Holdings PLC
30 April 2026
 

CLS Holdings plc

 

(the "Company", the "Group")

 

Notification of Transaction of Persons Discharging Managerial Responsibilities ("PDMR")

 

CLS Holdings plc Long Term Incentive Plan ("LTIP")

 

 

CLS Holdings plc announces that Fredrik Widlund, Chief Executive Officer and Director of the Company, and Harry Stokes, Chief Financial Officer and Director of the Company, have been awarded nil cost options over a number of ordinary shares of 2.5 pence each in the Company ("Ordinary Shares") as set out below (the "Awards") on 29 April 2026.

 

PDMR Plan Participant

Award Plan

No of Ordinary Shares granted pursuant to Awards

Award Type

Fredrik Widlund

 

LTIP

 

950,407

Performance Share Award

475,203

Restricted Share Award

Harry Stokes

LTIP

443,877

Performance Share Award

221,938

Restricted Share Award

 

The terms of the Awards align to the new hybrid award policy envisaged under the new Directors' Remuneration Policy approved at the 2026 Annual General Meeting and as set out in the Annual Report and Accounts 2025.

 

Subject to the LTIP rules, the Awards will vest on the third anniversary of the date of grant, subject to continued service and the achievement of performance targets or underpin conditions (as relevant). Details of performance targets and underpin conditions can be found in the Directors' Remuneration Report within the Company's Annual Report and Accounts 2025.

 

Vested Awards will be subject to an additional two-year holding period (net of sales for tax).

 

The notification is made in accordance with the UK Market Abuse Regulation.

 

Enquiries:

David Fuller

Company Secretary

CLS Holdings plc

Tel: +44 (0) 20 7582 7766

 

Notification of Dealing Form

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name(s)

Fredrik Widlund

2

 

Reason for the notification

a)

Position/status

 

Chief Executive Officer

 

b)

Initial notification/amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

CLS Holdings plc

b)

LEI

 

213800A357TKB2TD9U78

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument

Ordinary Shares of 2.5p

 

Identification code: GB00BF044593

 

b)

Nature of the transaction

Award of nil cost options under the CLS Holdings plc Long Term Incentive Plan

c)

Price(s) and volume(s)

 Price

 

Volume

 

1. Nil

2. Nil

1. 950,407 (PSA)

2. 475,203 (RSA)

d)

- Aggregated information

- Price

 

N/A single transactions

Nil

e)

Date of the transaction

 

29 April 2026

f)

Place of the transaction

Outside a trading venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name(s)

Harry Stokes

2

 

Reason for the notification

a)

Position/status

 

Chief Financial Officer

 

b)

Initial notification/amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

CLS Holdings plc

b)

LEI

 

213800A357TKB2TD9U78

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument

Ordinary Shares of 2.5p

 

Identification code: GB00BF044593

 

b)

Nature of the transaction

Award of nil cost options under the CLS Holdings plc Long Term Incentive Plan

c)

Price(s) and volume(s)

 Price

 

Volume

 

1. Nil

2. Nil

1. 443,877 (PSA)

2. 221,938 (RSA)

d)

- Aggregated information

- Price

 

N/A single transactions

Nil

e)

Date of the transaction

 

29 April 2026

 

f)

Place of the transaction

Outside a trading venue

 

 

- end -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKKBKBBKDNQN
Date   Source Headline
11th Apr 20254:09 pmRNSDirector/PDMR Shareholding
8th Apr 20253:43 pmRNSDirector/PDMR Shareholding
3rd Apr 20254:48 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAnnual Financial Report
27th Mar 20257:00 amRNSSale of Spring Mews Student
19th Mar 20257:31 amRNSDirector Declaration
13th Mar 20255:02 pmRNSDirector/PDMR Shareholding
26th Feb 20255:53 pmRNSTrading Update Correction
24th Feb 20257:00 amRNSTrading Update 24 February 2025
11th Feb 20253:13 pmRNSDirector/PDMR Shareholding
6th Feb 20257:00 amRNSUpdated redevelopment plans for Spring Gardens
14th Jan 20255:26 pmRNSTransfer of Treasury Shares to EBT and TVR
10th Jan 20254:33 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSCLS leases 29,816 sf for 10 years at Fetter Lane
19th Dec 20247:00 amRNSCLS leases 9,600 sqm to the City of Dortmund
11th Dec 202412:46 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSTrading Update 12 November 2024
12th Nov 20245:21 pmRNSDirector/PDMR Shareholding
11th Oct 20241:51 pmRNSDirector/PDMR Shareholding
11th Sep 20244:19 pmRNSDirector/PDMR Shareholding
6th Sep 20241:51 pmRNSChange of Auditor
4th Sep 20247:00 amRNSCLS leases over 8,900 sqm in Hamburg, Germany
12th Aug 20243:24 pmRNSDirector/PDMR Shareholding
7th Aug 20247:01 amRNSCLS Holdings Half Year Report
7th Aug 20247:00 amRNSCLS leases 12,052 sqft at Artesian, Prescot Street
1st Aug 20247:00 amRNSNotice of Half Year Results
11th Jul 202411:24 amRNSDirector/PDMR Shareholding
28th Jun 20244:58 pmRNSDirector Declaration
24th Jun 20247:00 amRNSCLS development plans for Citadel Place, Vauxhall
17th Jun 20247:00 amRNSCLS announces conversion of Debussy, Paris
14th Jun 20245:32 pmRNSDirector/PDMR Shareholding
10th Jun 20247:00 amRNSCLS updates on further sales progress
17th May 202412:52 pmRNSDirector Declaration
9th May 202411:18 amRNSDirector/PDMR Shareholding
9th May 20249:17 amRNSDirector/PDMR Shareholding
25th Apr 20243:33 pmRNSResult of AGM
15th Apr 20247:00 amRNSCLS Announces the Sale of Westminster Tower
11th Apr 20244:34 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSCLS Investor Presentation: Investor Meet Company
22nd Mar 20245:31 pmRNSAnnual Financial Report
14th Mar 20244:12 pmRNSDirector/PDMR Shareholding
14th Mar 20244:12 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSAnnual Financial Report
28th Feb 202412:00 pmRNSNotice of Results
7th Feb 20245:37 pmRNSDirector/PDMR Shareholding
9th Jan 20245:27 pmRNSDirector/PDMR Shareholding
8th Dec 20235:40 pmRNSDirector/PDMR Shareholding
21st Nov 20234:57 pmRNSDirector/PDMR Shareholding
21st Nov 202311:13 amRNSDirector Declaration
15th Nov 20237:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.